[Infectious endocarditis 100 years after Osler].
Fernández-Guerrero
M L
ML
Departamento de Medicina, Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D004198:Disease Susceptibility; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000601:surgery; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D008712:Methicillin
La endocarditis infecciosa 100 años después de Osler.